30/08/2026
MHS at UPA 2026 | Advancing sickle cell diagnosis 🇺🇬
This week at the 22nd Annual Uganda Paediatric Association Conference, our team is sharing the science behind MicroScreen — MHS’s multi-analyte point-of-care immunoassay designed to differentiate sickle cell disease, sickle cell trait and normal haemoglobin.
Uganda carries a significant sickle cell burden. Expanding access to early, reliable and decentralised diagnosis is critical to improving outcomes for children.
Beyond showcasing a locally manufactured diagnostic, is a chance to exchange knowledge, strengthen clinical collaboration and expand access to testing.
Local science. Earlier diagnosis. Better outcomes for children.